Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: A meta-analysis of 17 case-control studies

Experimental and Therapeutic Medicine

Volumn 4, Issue 5, 2012, Pages 938-948

  Leng, Wei Dong ^a   Zeng, Xian Tao ^a   Chen, Yong Ji ^a   Duan, Xiao Li ^a   Niu, Yu Ming ^a   Long, Rong Pei ^a   Luo, Zhi Xiao ^a  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Cytochrome P450 2E1; Esophageal cancer; Mainland chinese; Meta analysis; Polymorphism

Indexed keywords

CYTOCHROME P450 2E1;

ARTICLE; CANCER RISK; CHINESE; DNA POLYMORPHISM; EMBASE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ETHNICITY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MEDLINE; META ANALYSIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

EID: 84866362815     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.687     Document Type: Article

References (58)

1. Szumiło J: Epidemiology and risk factors of the esophageal squamous cell carcinoma. Pol Merkur Lekarski 26: 82-85, 2009.
2. Zheng S, Vuitton L, Sheyhidin I, Vuitton DA, Zhang Y and Lu X: Northwestern China: a place to learn more on oesophageal cancer. Part one: behavioural and environmental risk factors. Eur J Gastroenterol Hepatol 22: 917-925, 2010.
3. Umar SB and Fleischer DE: Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol 5: 517-526, 2008.
4. Guo P and Li K: Trends in esophageal cancer mortality in China during 1987-2009: age, period and birth cohort analyzes. Cancer Epidemiol 36: 99-105, 2012.
5. Ibiebele TI, Hughes MC, Whiteman DC and Webb PM; Australian Cancer Study: Dietary patterns and risk of oesophageal cancers: a population-based case-control study. Br J Nutr 107: 1207-1216, 2011.
6. Brown LM, Devesa SS and Chow WH: Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 100: 1184-1187, 2008.
7. Holmes RS and Vaughan TL: Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 17: 2-9, 2007.
8. Kamangar F, Chow WH, Abnet CC and Dawsey SM: Environ mental causes of esophageal cancer. Gastroenterol Clin North Am 38: 27-57, 2009.
9. Kuwano H, Kato H, Miyazaki T, et al: Genetic alterations in esophageal cancer. Surg Today 35: 7-18, 2005.
10. Hagymási K and Tulassay Z: Risk factors for esophageal cancer, and possible genetic background. Orv Hetil 150: 407-413, 2009 (In Hungarian).
11. Yang CS and Ishizaki H: Deuterium isotope effect on the metabolism of N-nitrosodimethylamine and related compounds by cytochrome P4502E1. Xenobiotica 22: 1165-1173, 1992.
12. Raucy JL, Kraner JC and Lasker JM: Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit Rev Toxicol 23: 1-20, 1993.
13. Ingelman-Sundberg M, Ronis MJ, Lindros KO, Eliasson E and Zhukov A: Ethanol-inducible cytochrome P4502E1: regulation, enzymology and molecular biology. Alcohol Alcohol Suppl 2: 131-139, 1994.
14. Pentiuk OO, Kachula SO and Herych OKh: Cytochrome P4502E1. Polymorphism, physiological function, regulation, and role in pathology. Ukr Biokhim Zh 76: 16-28, 2004 (In Ukrainian).
15. Lucas D, Ménez C, Floch F, et al: Cytochromes P4502E1 and P4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic caucasians. Alcohol Clin Exp Res 20: 1033-1037, 1996.
16. Lin DX, Tang YM, Peng Q, Lu SX, Ambrosone CB and Kadlubar FF: Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. Cancer Epidemiol Biomarkers Prev 7: 1013-1018, 1998.
17. Tan W, Song N, Wang GQ, et al: Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev 9: 551-556, 2000.
18. Hori H, Kawano T, Endo M and Yuasa Y: Genetic polymerphisms of tobacco-and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility. J Clin Gastroenterol 25: 568-575, 1997.
19. Lu XM, Zhang YM, Lin RY, et al: Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China. World J Gastroenterol 11: 3651-3654, 2005.
20. Shi QL: Genetic susceptibility, environment risk factors and their interaction in esophageal cancer. PhD dissertation, 2000 (Available at: http://www.globethesis.com/?t=1104360185996737).
21. Gao CM, Takezaki T, Sugimura H, et al: The Impact of CYP2E1 RsaI, GSTT1 and GSTM1 polymorphisms on the risk of esophageal cancer. China Cancer 10: 346-349, 2001 (In Chinese).
22. Gao C, Takezaki T, Wu J, et al: Interaction between cytochrome P-450 2E1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese. Cancer Epidemiol Biomarkers Prev 11: 29-34, 2002.
23. Shi Y, Zhou XW, Zhou YK and Ren S: Analysis of CYP2E1, GSTMl genetic polymorphisms in relation to human lung Cancer and esophageal carcinoma. J Huazhong Univ Sci Tech 31: 14-17, 2002 (In Chinese).
24. Shi RH, Wang W, Yu LZ, Huang XY, Chen ZQ and Zhao ZQ: The association between cytochrome P-450 2E1 and Glutathione enzyme gene P1 gene polymorphisms and esophageal cancer susceptibility. Chin J Digestive Endoscopy 21: 392-394, 2004 (In Chinese).
25. Yin LH, Pu YP, Song YH, Hu X, Liu YZ and Kai HT: Polymor phisms of susceptible genes for esophageal cancer risk in Huaian population in Jiangsu province. Tumor 25: 357-361, 2005 (In Chinese).
26. Li H: Case-control study of the risk factors to esophageal carcinoma. MSc thesis, 2006 (Available at: http://globethesis.com/?t=2144360185452638).
27. Dong CX, Wu J, Jin Y and Zhang J: Correlation between genetic polymorphism of CYP2E1, GSTM1 and esophageal cancer in Gansu. Chin J Gastroenterol Hepatol 16: 115-118, 2007 (In Chinese).
28. Liu R, Yin LH and Pu YP: Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China. Chin Med J (Engl) 120: 1797-1802, 2007.
29. Guo YM, Wang Q, Liu YZ, Chen HM, Qi Z and Guo QH: Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males. World J Gastroenterol 14: 1444-1449, 2008.
30. Qin JM, Yang L, Chen B, et al: Interaction of methylenetetrahydrofolate reductase C677T, cytochrome P4502E1 polymorphism and environment factors in esophageal cancer in Kazakh population. World J Gastroenterol 14: 6986-6992, 2008.
31. Xia H, Zhou J and Chen HJ: The research on the relationship between CD44, CYP2E1 genetic polymorphisms and esophageal cancer. Chin Oncol 18: 195-198, 2008 (In Chinese).
32. Yang YF: A study on risk factors and biomarkers associated with the different stages of esophageal squamous cell carcinogenesis in Feicheng county. PhD dissertation, 2008 (Available at: http://www.globethesis.com/?t=1114360245996153).
33. Zhang B and Wu J: Correlation between genetic polymorphism of CYP2E1 and susceptibility of esophageal cancer in Gansu Province. J Chengde Med Coll 25: 245-248, 2008 (In Chinese).
34. Niu Y, Yuan H, Leng W, Pang Y, Gu N and Chen N: CYP2E1 RsaI/PstI polymorphism and esophageal cancer risk: a metaanalysis based on 1,088 cases and 2,238 controls. Med Oncol 28: 182-187, 2011.
35. Moher D, Liberati A, Tetzlaff J and Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339: b2535, 2009.
36. Higgins JP and Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558, 2002.
37. Higgins JP, Thompson SG, Deeks JJ and Altman DG: Measuring inconsistency in meta-analyses. BMJ 327: 557-560, 2003.
38. Egger M, Davey Smith G, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634, 1997.
39. Wang LD, Liu B, Feng CW, et al: Histopathological comparison of the lesions at esophagus, gastric cardia and antrum on the subjects from Linzhou, Henan and the Linzhou migrated from Changzhi, Shanxi. J Zhengzhou Univ (Medical Sciences) 41: 5-9, 2006.
40. Tran GD, Sun XD, Abnet CC, et al: Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 113: 456-463, 2005.
41. Morita M, Saeki H, Mori M, Kuwano H and Sugimachi K: Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract. Surgery 131 (Suppl 1): S1-S6, 2002.
42. Akbari MR, Malekzadeh R, Nasrollahzadeh D, et al: Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int J Cancer 119: 1047-1051, 2006.
43. Dhillon PK, Farrow DC, Vaughan TL, et al: Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer 93: 148-152, 2001.
44. Garavello W, Negri E, Talamini R, et al: Family history of cancer, its combination with smoking and drinking, and risk of squamous cell carcinoma of the esophagus. Cancer Epidemiol Biomarkers Prev 14: 1390-1393, 2005.
45. Tavani A, Negri E, Franceschi S and La Vecchia C: Risk factors for esophageal cancer in lifelong nonsmokers. Cancer Epidemiol Biomarkers Prev 3: 387-392, 1994.
46. Chak A, Lee T, Kinnard MF, et al: Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut 51: 323-328, 2002.
47. Li JY, Ershow AG, Chen ZJ, et al: A case-control study of cancer of the esophagus and gastric cardia in Linxian. Int J Cancer 43: 755-761, 1989.
48. Morita M, Kuwano H, Nakashima T, et al: Family aggregation of carcinoma of the hypopharynx and cervical esophagus: special reference to multiplicity of cancer in upper aerodigestive tract. Int J Cancer 76: 468-471, 1998.
49. Wang Z, Tang L, Sun G, et al: Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China. BMC Cancer 6: 287, 2006.
50. Yu Y, Taylor PR, Li JY, et al: Retrospective cohort study of risk-factors for esophageal cancer in Linxian, People's Republic of China. Cancer Causes Control 4: 195-202, 1993.
51. Tian F, Cheng QS and Yu LL: Meta-analysis of risk factors of esophageal cancer in China. Journal of the Fourth Military Medical University 24: 2196-2198, 2003 (In Chinese).
52. Liu YX, Wang B, Wan MH, Tang WF, Huang FK and Li C: Meta-analysis of the relationship between the metholenetetrahy-drofolate reductase C677T genetic polymorphism, folate intake and esophageal cancer. Asian Pac J Cancer Prev 12: 247-252, 2011.
53. Moaven O, Raziee HR, Sima HR, et al: Interactions between glutathione-S-transferase M1, T1 and P1 polymorphisms and smoking, and increased susceptibility to esophageal squamous cell carcinoma. Cancer Epidemiol 34: 285-290, 2010.
54. Tong Z, ZhuGe J and Yu Y: Researches on the polymorphism of cytochrome P450 2A6. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19: 424-427, 2002 (In Chinese).
55. Xing DY, Tan W, Song N and Lin DX: Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer 95: 140-143, 2001.
56. Huang J, Zhang J, Zhao Y, et al: The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese mainland population: a meta-analysis. Mol Biol Rep 38: 4565-4573, 2011.
57. Zhao Y, Wang F, Shan S, et al: Genetic polymorphism of p53, but not GSTP1, is association with susceptibility to esophageal cancer risk - a meta-analysis. Int J Med Sci 7: 300-308, 2010.
58. Hayashi S, Watanabe J and Kawajiri K: Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 110: 559-565, 1991.